Leave feedback

AnalytiCon Discovery, GmbH


Logo

Company Logo - AnalytiCon Discovery, GmbH


Contact Data

Phone number: 49-331-2300-300
Fax number: 49-331-2300-333
More information: MolPort & AnalytiCon webinar on AnalytiCon's unique chemical space
Address line 1: Hermannswerder Haus 17
Address line 2:
City: Potsdam
State/Province/Region:
Zip/Postal code: 14473
Country: Germany
Web page: http://www.ac-discovery.com


Notes

AnalytiCon Discovery GmbH is a biotechnology company focusing on the development of compound libraries consisting of natural product and synthetic small molecules. Database contains more than 25,000 pure natural product small molecules, with over 40% of them representing novel structures.



Compounds

First Previous Previous 1 2 3 4 5 6 Next Next Last

# Catalog Number IUPAC
1. FRG-00279 (6R)-4-benzyl-1,4-oxazepan-6-ol
2. FRG-00284 ethyl 2-(N-benzyl-1-cyclopropylformamido)acetate
3. FRG-00285 ethyl 4-(furan-2-carbonyl)piperazine-1-carboxylate
4. FRG-00286 1-benzyl-4-(furan-2-carbonyl)piperazine
5. FRG-00287 1-(furan-2-carbonyl)-4-(pyridin-2-yl)piperazine
6. FRG-00288 1-(4-benzylpiperazin-1-yl)-2,2-dimethylpropan-1-one
7. FRG-00290 (2E)-3-phenyl-1-[4-(pyridin-2-yl)piperazin-1-yl]prop-2-en-1-one
8. FRG-00291 1-(2-methylbenzoyl)-4-(pyridin-2-yl)piperazine
9. FRG-00292 1-cyclopentanecarbonyl-4-(pyridin-2-yl)piperazine
10. NP-003504 5,11,17,19-tetrahydroxy-15-methyl-2-oxapentacyclo[9.8.0.0¹,³.0⁴,⁹.0¹²,¹⁷]nonadeca-4,6,8-triene-10,13-dione
11. NP-016820 7-{[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-5-hydroxy-2-(4-hydroxyphenyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-4H-chromen-4-one
12. NP-016828 (6E,10E)-12-(2,6-dihydroxy-4-methylphenyl)-2,6,10-trimethyl-4-oxododeca-6,10-dien-5-yl acetate
13. NP-016829 2-[(2E)-3,7-dimethylocta-2,6-dien-1-yl]-1,3-dimethoxy-5-methylbenzene
14. NP-020080 {3-hydroxy-7,14-dimethoxy-17-methyl-5-oxo-12,16,21-trioxapentacyclo[15.3.1.0²,¹⁵.0⁴,¹³.0⁶,¹¹]henicosa-2(15),3,6,8,10,13-hexaen-8-yl}oxidanesulfonic acid
15. NP-020084 (2Z)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoic acid
16. NP-003502 methyl (1S,2R,4R,8R,9S,10R,13R,15R)-2-(acetyloxy)-13-(furan-3-yl)-9-(2-methoxy-2-oxoethyl)-4,8,10,12-tetramethyl-7-oxo-16-oxatetracyclo[8.6.0.0³,⁸.0¹¹,¹⁵]hexadeca-5,11-diene-4-carboxylate
17. NP-004833 1-acetyl-1,3a,3b-trihydroxy-7-{[5-({5-[(3-hydroxy-4-methoxy-6-methyl-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-4-methoxy-6-methyloxan-2-yl}oxy)-4-methoxy-6-methyloxan-2-yl]oxy}-9a,11a-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-11-yl benzoate
18. NP-003501 (4aS)-6,7-dihydroxy-1,1,4a-trimethyl-1,2,3,4,4a,9,10,10a-octahydrophenanthren-9-one
19. NP-020089 (1S,3R,4S,12R,14S,17S,20S)-4,8,8,12-tetramethyl-17-(2-methylpropyl)-13,15,18-triazaheptacyclo[11.8.6.0¹,¹⁴.0³,¹².0⁴,⁹.0¹⁵,²⁰.0²²,²⁷]heptacosa-22,24,26-triene-16,19-dione
20. NP-019088 (2S,3R,4S,5S)-3-{[(2S,3R,4S,5R,6S)-5-{[(2S,3R,4S,5R)-4-{[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}-3,5-dihydroxyoxan-2-yl]oxy}-3,4-dihydroxy-6-methyloxan-2-yl]oxy}-4,5-dihydroxyoxan-2-yl (4aR,5R,6aS,6bR,10R,11S,12aR,14bS)-10-{[(2R,3R,4S,5R,6R)-3,5-dihydroxy-6-(hydroxymethyl)-4-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-5,11-dihydroxy-9,9-bis(hydroxymethyl)-2,2,6a,6b,12a-pentamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylate
21. NP-003517 5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-6-(3-methylbut-2-en-1-yl)-3,4-dihydro-2H-1-benzopyran-4-one
22. NP-019085 (2S,3R,4S,5S)-3-{[(2S,3R,4S,5R,6S)-5-{[(2S,3R,4S,5R)-4-{[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}-3,5-dihydroxyoxan-2-yl]oxy}-3,4-dihydroxy-6-methyloxan-2-yl]oxy}-4,5-dihydroxyoxan-2-yl (4aR,5R,6aS,6bR,10R,11S,12aR,14bS)-5,11-dihydroxy-9,9-bis(hydroxymethyl)-2,2,6a,6b,12a-pentamethyl-10-{[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylate
23. NP-019086 (2S,3R,4S,5S)-3-{[(2S,3R,4S,5R,6S)-5-{[(2S,3R,4S,5R)-4-{[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}-3,5-dihydroxyoxan-2-yl]oxy}-3,4-dihydroxy-6-methyloxan-2-yl]oxy}-4,5-dihydroxyoxan-2-yl (4aR,5R,6aS,6bR,10R,11S,12aR,14bS)-5,11-dihydroxy-9,9-bis(hydroxymethyl)-2,2,6a,6b,12a-pentamethyl-10-{[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylate
24. NP-003511 (3S,6R,6aS,7S)-6,6a,7,8-tetrahydroxy-3-methyl-1,2,3,4,5,6,6a,7,12,12a-decahydrotetraphene-1,12-dione
25. NP-004813 (1R,2S,3R,5S,6R,8aR)-5-[2-(furan-3-yl)ethyl]-5,6,8a-trimethyl-octahydro-2H-spiro[naphthalene-1,2'-oxirane]-2,3-diol
26. NP-004815 (2E)-5-[(1S,8aS)-5,5,8a-trimethyl-2-methylidene-decahydronaphthalen-1-yl]-3-methylpent-2-enoic acid
27. NP-019075 (2R,3S,4S,5R,6R)-2-({[(2R,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-6-({6,6-dimethylbicyclo[3.1.1]heptan-2-yl}methoxy)oxane-3,4,5-triol
28. NP-007084 methyl (2E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoate
29. NP-004811 (4S,5S,6E,8S,10R)-4,5,8-trihydroxy-10-methyl-3,4,5,8,9,10-hexahydro-2H-oxecin-2-one
30. NP-004810 2-[1-(4-nitrobenzoyl)pyrrolidine-2-amido]benzoic acid
31. NP-019082 7-(2-hydroxypropan-2-yl)-4a-methyl-1-methylidene-decahydronaphthalen-2-yl acetate
32. NP-019067 (2S,3S,4S,5R,6R)-6-{[(3S,4S,6aR,6bS,8R,8aR,12aS,14bR)-8a-({[(2S,3R,4S,5S,6R)-5-(acetyloxy)-4-{[(2S,3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-3-{[(2S,3R,4S,5R,6S)-3,4-dihydroxy-6-methyl-5-{[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}carbonyl)-4-formyl-8-hydroxy-4,6a,6b,11,11,14b-hexamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yl]oxy}-3,4-dihydroxy-5-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxane-2-carboxylic acid
33. NP-019065 2-(6-hydroxy-3,8-dimethyl-2-oxo-1,2,4,5,6,7,8,8a-octahydroazulen-5-yl)prop-2-enoic acid
34. NP-019066 (2S,3S,4S,5R,6R)-6-{[(3S,4S,6aR,6bS,8R,8aR,12aS,14bR)-8a-({[(2S,3R,4S,5R,6R)-3-{[(2S,3R,4S,5R,6S)-5-{[(2S,3R,4S,5R)-3,5-dihydroxy-4-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyl-5-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}carbonyl)-4-formyl-8-hydroxy-4,6a,6b,11,11,14b-hexamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yl]oxy}-3,4-dihydroxy-5-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxane-2-carboxylic acid
35. NP-004826 (5E)-4-methoxy-5-{methoxy[(2R,3S)-3-phenyloxiran-2-yl]methylidene}-2,5-dihydrofuran-2-one
36. NP-020050 4-acetamido-4-{[2-(4-hydroxyphenyl)ethyl]carbamoyl}butanoic acid
37. NP-020052 3,7-dihydroxy-14-methoxy-17-methyl-12,16,21-trioxapentacyclo[15.3.1.0²,¹⁵.0⁴,¹³.0⁶,¹¹]henicosa-2(15),3,6,8,10,13-hexaen-5-one
38. NP-020053 2-hydroxy-3-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}propyl (9Z)-hexadec-9-enoate
39. NP-003548 1-(2-hydroxy-4-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-3-(4-hydroxyphenyl)propan-1-one
40. NP-004878 (12Z)-9,10,11-trihydroxyoctadec-12-enoic acid
41. NP-002218 7-{[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-3,5-dihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one
42. NP-014205 7'-hydroxy-6'-methoxy-2'-methyl-3',4',6,8-tetrahydro-2H,2'H-spiro[indeno[4,5-d][1,3]dioxole-7,1'-isoquinolin]-8-one
43. NP-015530 1,4',5',8,10-pentahydroxy-2',6-bis(hydroxymethyl)-9',10-bis[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-9H,9'H,10H,10'H-[2,9'-bianthracene]-9,10'-dione
44. NP-015532 1,4',5',8,10-pentahydroxy-2',6-bis(hydroxymethyl)-9',10-bis[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-9H,9'H,10H,10'H-[2,9'-bianthracene]-9,10'-dione
45. NP-015537 2-(4-hydroxy-2-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)acetonitrile
46. NP-015538 2-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-2-(4-hydroxyphenyl)acetonitrile
47. NP-002212 (1S,4aS,7S,7aS)-7-hydroxy-7-methyl-1-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[(4-hydroxybenzoyloxy)methyl]oxan-2-yl]oxy}-1H,4aH,5H,6H,7H,7aH-cyclopenta[c]pyran-4-carboxylic acid
48. NP-002213 (1S,4aS,7S,7aS)-1-{[(2S,3R,4S,5S,6R)-6-({[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-7-hydroxy-7-methyl-1H,4aH,5H,6H,7H,7aH-cyclopenta[c]pyran-4-carboxylic acid
49. NP-002214 [(1S,4aR,5S,7aS)-5-hydroxy-1-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1H,4aH,5H,7aH-cyclopenta[c]pyran-7-yl]methyl (2E)-3-(4-hydroxyphenyl)prop-2-enoate
50. NP-003540 (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-{[4-(4-hydroxyphenyl)butan-2-yl]oxy}oxane-3,4,5-triol

First Previous Previous 1 2 3 4 5 6 Next Next Last

 
2021 MolPort, v4.86, release date 25-07-2021 17:00 (+0200). All rights reserved.
This website or its third-party tools use cookies, which are necessary to its functioning and require to achieve the purposes illustrated in the Cookie Policy. If you want to know more or withdraw your consent to all or some of the cookies, please refer to the Cookie Policy. By clicking on Agree and closing this banner, scrolling this page, clicking a link or continuing to browse otherwise, you agree to the use of cookies.